RAME GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: Y00969 | TORPOINT, PL11 2TB
Showing results 101-150 of 656
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sildenafil (Erectile Dysfunction) | 670 | 6,896 | £948 | +32.9% ▲ |
| Mirabegron | 666 | 21.3K | £19.6K | +65.8% ▲ |
| Estradiol with progestogen | 664 | 21.7K | £20.8K | +94.8% ▲ |
| Oxycodone hydrochloride | 660 | 66.8K | £11.4K | +157.9% ▲ |
| Donepezil hydrochloride | 659 | 16.8K | £619 | +113.6% ▲ |
| Mebeverine hydrochloride | 655 | 51.8K | £2.1K | +110.9% ▲ |
| Buprenorphine | 632 | 2,677 | £12.2K | +72.5% ▲ |
| Solifenacin | 628 | 21.0K | £785 | +31.6% ▲ |
| 618 | 72.0K | £3.1K | +30.3% ▲ | |
| Thiamine hydrochloride | 583 | 33.7K | £884 | +10.6% ▲ |
| Diltiazem hydrochloride | 574 | 24.5K | £5.2K | +86.9% ▲ |
| Prochlorperazine maleate | 574 | 31.1K | £2.1K | +184.0% ▲ |
| Cyanocobalamin | 553 | 27.7K | £2.6K | +56.7% ▲ |
| Olanzapine | 546 | 14.0K | £1.6K | +47.4% ▲ |
| Combined ethinylestradiol 30mcg | 540 | 37.1K | £2.2K | +94.4% ▲ |
| Clobetasone butyrate | 512 | 26.3K | £5.1K | +150.9% ▲ |
| Eplerenone | 505 | 13.2K | £1.6K | +90.4% ▲ |
| Mometasone furoate | 504 | 548 | £4.2K | +25.5% ▲ |
| Quetiapine | 485 | 19.7K | £7.2K | -22.1% ▼ |
| Carbomer 940/980 | 484 | 11.1K | £2.3K | +217.8% ▲ |
| Estriol | 483 | 9,266 | £7.8K | +127.0% ▲ |
| Celecoxib | 477 | 25.8K | £1.7K | +622.3% ▲ |
| Insulin aspart | 476 | 3,536 | £22.3K | +25.0% ▲ |
| Estradiol | 463 | 11.7K | £5.6K | +71.6% ▲ |
| Nifedipine | 454 | 20.9K | £6.0K | +142.3% ▲ |
| Levetiracetam | 453 | 37.4K | £3.9K | -1.0% vs avg |
| Felodipine | 450 | 15.7K | £1.6K | -24.2% ▼ |
| Clarithromycin | 446 | 10.4K | £1.9K | +81.8% ▲ |
| Aripiprazole | 437 | 10.4K | £1.6K | +71.7% ▲ |
| Tiotropium bromide | 436 | 6,901 | £11.9K | +43.4% ▲ |
| Insulin glargine | 434 | 2,446 | £22.0K | +52.9% ▲ |
| Hyoscine butylbromide | 430 | 48.0K | £3.4K | +84.5% ▲ |
| Sacubitril/valsartan | 428 | 24.4K | £39.8K | +78.7% ▲ |
| Tolterodine | 422 | 18.5K | £3.5K | +183.8% ▲ |
| Metoclopramide hydrochloride | 418 | 21.9K | £955 | +404.5% ▲ |
| Risperidone | 416 | 18.4K | £4.7K | +64.4% ▲ |
| 403 | 640 | £873 | +82.9% ▲ | |
| 403 | 37.5K | £2.5K | +86.3% ▲ | |
| Lactulose | 402 | 203.7K | £1.9K | +22.1% ▲ |
| Perindopril erbumine | 400 | 14.5K | £1.2K | -24.6% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 399 | 32.2K | £1.3K | +30.2% ▲ |
| Mometasone furoate | 399 | 30.0K | £2.8K | +198.4% ▲ |
| Lercanidipine hydrochloride | 395 | 13.8K | £1.5K | -36.1% ▼ |
| Letrozole | 394 | 13.1K | £1.2K | +111.0% ▲ |
| Sodium valproate | 392 | 55.6K | £6.4K | +23.2% ▲ |
| Trimethoprim | 389 | 9,112 | £660 | +90.4% ▲ |
| Betahistine hydrochloride | 386 | 34.8K | £1.4K | +61.7% ▲ |
| Aciclovir | 380 | 18.8K | £868 | +155.5% ▲ |
| 380 | 397 | £2.2K | +60.9% ▲ | |
| Fluticasone/umeclidinium/vilanterol | 379 | 394 | £16.7K | +61.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.